Study of NTLA-2001 for Patients with Transthyretin Amyloidosis and Heart Disease
- Substances:DexamethasoneFamotidine+4
The Netherlands- Participants:18–64 years · 65+ years
- Substances:Dexamethasone
- Sponsor:Intellia Therapeutics Inc.
Rare diseases
Investigational molecules
Locations
Back to the Netherlands330 clinical trials in Maastricht, The Netherlands across 6 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)
The NetherlandsStudy of cefuroxime and metronidazole to prevent infections after Whipple's procedure in patients with high risk of bile contamination
The NetherlandsLong-Term Safety Study of BCMACP03, BCN-CP01, and 19CP02 for Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma, CLL, SLL, or Multiple Myeloma
The NetherlandsStudy on the Long-Term Safety of Aficamten (CK-3773274) for Patients with Symptomatic Hypertrophic Cardiomyopathy
The NetherlandsStudy on Personalized Dosing of Emicizumab for Patients with Congenital Hemophilia A
The NetherlandsStudy on the Effectiveness of Floxuridine and Drug Combination for Patients with Unresectable Colorectal Liver Metastases
The NetherlandsStudy on Fertility Preservation in Women with Stage IB2 Cervical Cancer Using Cisplatin, Carboplatin, and Paclitaxel Before Surgery
The NetherlandsStudy on Prednisolone for Women with Unexplained Recurrent Miscarriages
The NetherlandsStudy on Metamizole Sodium Monohydrate for Pain Relief in Patients with Chronic Pancreatitis Diagnosed Less Than 3 Years Ago
The NetherlandsStudy on Omega-3 Fatty Acids for Reducing Organ Failure and Mortality in Patients with Severe Acute Pancreatitis
The NetherlandsStudy on Personalized Antithrombotic Therapy with Acenocoumarol, Phenprocoumon, and Apixaban for Patients with Aortic Valve Stenosis Post-TAVI
The Netherlands
The NetherlandsThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on colorectal cancer, breast cancer, and melanoma treatments. Studies include novel therapy combinations and personalized treatment approaches.
Particular emphasis on targeted therapies and treatment optimization for various cancer types.
Research focusing on chronic kidney disease, fibromyalgia, and inflammatory bowel conditions. Studies evaluate new therapeutic approaches and treatment combinations.
Emphasis on developing effective long-term management strategies for chronic conditions.
Investigations into peripheral arterial disease and cardiomyopathy treatments. Research includes innovative therapeutic approaches and preventive strategies.
Focus on improving patient outcomes through targeted interventions and preventive measures.
Tell us about your condition – we search every trial in Europe and connect you with the right site.